What is a biosimilar?

A biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product. When patients are prescribed a biological product, biosimilar and interchangeable products can offer additional treatment options, potentially lowering health care costs.

However, despite the health benefits of biosimilars, they are not yet widely available in the U.S. due to a variety of factors, including misinformation about the efficacy of biosimilars, efforts by some manufacturers to extend their patent protection, and rebates granted by some manufacturers to insurers and pharmacy benefit managers to cover biologics and not biosimilars.

We need policymakers to take action to increase access to biosimilars for patients living with chronic conditions. Sign up to tell legislators to cut health care costs by making biosimilars more accessible!